Klear generates $814/mo revenue with an exceptional 70% profit margin ($570/mo), trading at just 0.73x annual profit — a remarkable valuation floor that reflects either very early traction or potential data transparency issues worth confirming. The health & fitness niche is competitive but recurring app models can sustain if retention and churn are strong. Financials are platform-verified, which adds confidence, though buyer should independently confirm customer count, active users, churn rate, and the sustainability of the current revenue base before committing.
The core software—a personalized skincare app with daily missions, progress tracking, and routine recommendations—is reproducible in 8 weeks using AI coding tools (e.g., Claude or ChatGPT Pro), React Native or Flutter for mobile, Firebase or Supabase for backend, and third-party APIs for payment and push notifications. Estimated cash outlay: $3.5–$8K (AI subscriptions, hosting, domain, and basic infrastructure). However, the decisive advantage of buying is the acquired customer base, verified revenue stream, and operational proof-of-concept. At $5K asking price against a $34.2K annual profit run-rate ($570 × 12), the valuation is sufficiently attractive to justify acquisition over building from zero. The primary risk is confirming that the 814/mo is durable and not concentrated in a small, at-risk user cohort; if churn is high or customer concentration is acute, the build case strengthens.
Cash estimate includes the AI tools, APIs and infrastructure needed for a solo founder to recreate the software. Build time is informational and lightly weighted. The verdict is driven mainly by customers, users, verified earnings, retention, distribution, brand, data and operating history.
Klear is a personalized acne-care app designed to help users achieve clearer skin with a simple, structured 30-day plan. Users receive a tailored skincare routine, daily missions, progress tracking, a
Opens the original listing on TrustMRR
Get new listings with asking prices, monthly profit, deal scores, and key risks.
The best reviewed deals, concise and evidence-first. Unsubscribe anytime.
Preliminary screening based on marketplace and public data. Verify all financial, legal, technical, customer, and operational claims independently before making an acquisition decision. This is not financial or legal advice.